Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) Who receive neoadjuvant chemotherapy: Results from ACO SOG Z107 1 (Alliance)

Annals of Surgery

Volumn 263, Issue 4, 2016, Pages 802-807

  Boughey, Judy C ^a   Ballman, Karla V ^a   Le Petross, Huong T ^b   McCall, Linda M ^c   Mittendorf, Elizabeth A ^b   Ahrendt, Gretchen M ^d   Wilke, Lee G ^e   Taback, Bret ^f   Feliberti, Eric C ^g   Hunt, Kelly K ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e University of Wisconsin Health   (United States)

^f Department of Medicine   (United States)

^g EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Axillary ultrasound; Clipped node; Neoadjuvant chemotherapy; Node positive breast cancer; Sentinel lymph node

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CLIP; FALSE NEGATIVE RESULT; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; NEEDLE BIOPSY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE SURGERY; ADJUVANT CHEMOTHERAPY; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FIDUCIAL MARKER; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; FALSE NEGATIVE REACTIONS; FEMALE; FIDUCIAL MARKERS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84949457727     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001375     Document Type: Article

References (23)

1. Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg. 1997;21:270-274.
2. Garcia-Ortega MJ, Benito MA, Vahamonde EF, et al. Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: diagnostic accuracy and impact on management. Eur J Radiol. 2011;79:64-72.
3. Koelliker SL, Chung MA, Mainiero MB, et al. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer-correlation with primary tumor size. Radiology. 2008;246:81-89.
4. Ciatto S, Brancato B, Risso G, et al. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat. 2007;103:85-91.
5. Altomare V, Guerriero G, Carino R, et al. Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature. Surg Today. 2007;37:735-739.
6. Alkuwari E, Auger M. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer. 2008;114:89-93.
7. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002;95:982-988.
8. Boughey JC, Moriarty JP, Degnim AC, et al. Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol. 2010;17:953-958.
9. van Rijk MC, Deurloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol. 2006;13:31-35.
10. Alvarez S, Anorbe E, Alcorta P, et al. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006;186:1342-1348.
11. Hieken TJ, Trull BC, Boughey JC, et al. Preoperative axillary imaging with percutaneouslymphnode biopsyisvaluableinthecontemporarymanagementof patients with breast cancer. Surgery. 2013;154:831-838; discussion 838-840.
12. Caudle AS, Kuerer HM, Le-Petross HT, et al. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol. 2014;21:3440-3447.
13. Verheuvel NC, van den Hoven I, Ooms HWA, et al. The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol. 2015;22:409-415.
14. Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg. 2014; 260:608-614; discussion 614-616.
15. Dominici LS, Negron Gonzalez VM, Buzdar AU, et al. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoper-ative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010;116:2884-2889.
16. Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455-1461.
17. Nathanson SD, Burke M, Slater R, et al. Preoperative identification of the sentinel lymph node inbreast cancer. Ann Surg Oncol. 2007;14:3102-3110.
18. Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neo-adjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 trial (Alliance). J Clin Oncol. 2015 [Epub ahead of print].
19. Caudle AS, Yang WT, Mittendorf EA, et al. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015;150:137-143.
20. Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261:378-382.
21. Choy N, Lipson J, Porter C, et al. Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol. 2015;22:377-382.
22. Mittendorf EA, Caudle AS, Yang W, et al. Implementation of the American College of Surgeons Oncology Group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014;21:2468-2473.
23. National Comprehensive Cancer Network (NCCN) guidelines version2.2015. Preoperative systemic therapy breast and axillary evaluation. Available at: http://www.nccn.org/professionals/physician-gls/PDF/breast.pdf. Accessed March 28, 2015.